Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Can Sanofi Catch Up With Amgen Now That Praluent Has CV Risk-Reduction Claim?
Like Repatha, Praluent now has CV outcomes data in its US label.
More from Cardiovascular
More from Therapeutic Category